US 3929992A
· Sehgal et al.
· 1975
[cited by applicant]
US 4316885A
· Rakhit
· 1982
[cited by applicant]
US 4366241A
· Tom et al.
· 1982
[cited by applicant]
US 4376110A
· David et al.
· 1983
[cited by applicant]
US 4382445A
· Sommers
· 1983
[cited by applicant]
US 4517288A
· Giegel et al.
· 1985
[cited by applicant]
US 4650803A
· Stella et al.
· 1987
[cited by applicant]
US 4655745A
· Corbett
· 1987
[cited by applicant]
US 4830849A
· Osterholm
· 1989
[cited by applicant]
US 4837168A
· de Jaeger et al.
· 1989
[cited by applicant]
US 4950232A
· Ruzicka et al.
· 1990
[cited by applicant]
US 5023263A
· Von Burg
· 1991
[cited by applicant]
US 5023264A
· Caufield et al.
· 1991
[cited by applicant]
US 5100883A
· Schiehser
· 1992
[cited by applicant]
US 5118677A
· Caufield
· 1992
[cited by applicant]
US 5118678A
· Kao et al.
· 1992
[cited by applicant]
US 5120842A
· Failli et al.
· 1992
[cited by applicant]
US 5130307A
· Failli et al.
· 1992
[cited by applicant]
US 5162333A
· Failli et al.
· 1992
[cited by applicant]
US 5177203A
· Failli et al.
· 1993
[cited by applicant]
US 5221670A
· Caufield
· 1993
[cited by applicant]
US 5233036A
· Hughes
· 1993
[cited by applicant]
US 5256790A
· Nelson
· 1993
[cited by applicant]
US 5258389A
· Goulet et al.
· 1993
[cited by applicant]
US 5260300A
· Hu
· 1993
[cited by applicant]
US 5262423A
· Kao
· 1993
[cited by applicant]
US 5302584A
· Kao et al.
· 1994
[cited by applicant]
US 5362718A
· Skotnicki et al.
· 1994
[cited by applicant]
US 5373014A
· Failli et al.
· 1994
[cited by applicant]
US 5378836A
· Kao et al.
· 1995
[cited by applicant]
US 5385908A
· Nelson et al.
· 1995
[cited by applicant]
US 5385909A
· Nelson et al.
· 1995
[cited by applicant]
US 5385910A
· Ocain et al.
· 1995
[cited by applicant]
US 5389639A
· Failli et al.
· 1995
[cited by applicant]
US 5391730A
· Skotnicki et al.
· 1995
[cited by applicant]
US 5405316A
· Magram
· 1995
[cited by applicant]
US 5411967A
· Kao et al.
· 1995
[cited by applicant]
US 5434260A
· Skotnicki et al.
· 1995
[cited by applicant]
US 5463048A
· Skotnicki et al.
· 1995
[cited by applicant]
US 5470318A
· Griffith, III et al.
· 1995
[cited by applicant]
US 5480988A
· Failli et al.
· 1996
[cited by applicant]
US 5480989A
· Kao et al.
· 1996
[cited by applicant]
US 5489680A
· Failli et al.
· 1996
[cited by applicant]
US 5491231A
· Nelson et al.
· 1996
[cited by applicant]
US 5504091A
· Molnar-Kimber et al.
· 1996
[cited by applicant]
US 5531673A
· Helenowski
· 1996
[cited by applicant]
US 5563145A
· Failli et al.
· 1996
[cited by applicant]
US 5665772A
· Cottens et al.
· 1997
[cited by applicant]
US 5780462A
· Lee et al.
· 1998
[cited by applicant]
US 5957912A
· Heitzmann
· 1999
[cited by applicant]
US 6193691B1
· Beardsley
· 2001
[cited by applicant]
US 6210346B1
· Hall et al.
· 2001
[cited by applicant]
US 6273913B1
· Wright et al.
· 2001
[cited by applicant]
US 6277983B1
· Shaw et al.
· 2001
[cited by applicant]
US 6358969B1
· Shelley et al.
· 2002
[cited by applicant]
US 6471960B1
· Anderson
· 2002
[cited by applicant]
US 6585764B2
· Wright et al.
· 2003
[cited by applicant]
US 6599275B1
· Fischer, Jr.
· 2003
[cited by applicant]
US 6670168B1
· Katz et al.
· 2003
[cited by applicant]
US 6689085B1
· Rubenstein et al.
· 2004
[cited by applicant]
US 6696488B2
· Wolfe et al.
· 2004
[cited by applicant]
US 6808536B2
· Wright et al.
· 2004
[cited by applicant]
US 6916310B2
· Sommerich
· 2005
[cited by applicant]
US 7025739B2
· Saul
· 2006
[cited by applicant]
US 7037288B2
· Rosenberg et al.
· 2006
[cited by applicant]
US 7331940B2
· Sommerich
· 2008
[cited by applicant]
US 7662140B2
· Heruth et al.
· 2010
[cited by applicant]
US 7717871B2
· Odland
· 2010
[cited by applicant]
US 7763142B2
· Watson
· 2010
[cited by applicant]
US 7811279B2
· John
· 2010
[cited by applicant]
US 7887503B2
· Geiger
· 2011
[cited by applicant]
US 8088091B2
· Thomas et al.
· 2012
[cited by applicant]
US 8137334B2
· Heruth et al.
· 2012
[cited by applicant]
US 8206334B2
· Kralick et al.
· 2012
[cited by applicant]
US 8216173B2
· Dacey, Jr. et al.
· 2012
[cited by applicant]
US 8292856B2
· Bertrand et al.
· 2012
[cited by applicant]
US 8435204B2
· Lad et al.
· 2013
[cited by applicant]
US 9097723B2
· Fathollahi et al.
· 2015
[cited by applicant]
US 9138537B2
· Miesel
· 2015
[cited by applicant]
US 9220424B2
· Wilson et al.
· 2015
[cited by applicant]
US 9421348B2
· Lenihan et al.
· 2016
[cited by applicant]
US 9603792B2
· John
· 2017
[cited by applicant]
US 9629987B2
· Anand et al.
· 2017
[cited by applicant]
US 9682193B2
· Anand et al.
· 2017
[cited by applicant]
US 9687670B2
· Dacey, Jr. et al.
· 2017
[cited by applicant]
US 9744338B2
· East et al.
· 2017
[cited by applicant]
US 9770180B2
· Radojicic
· 2017
[cited by applicant]
US 9895518B2
· Lad et al.
· 2018
[cited by applicant]
US 9913886B2
· Kyutoku et al.
· 2018
[cited by applicant]
US 9919138B2
· Lenihan et al.
· 2018
[cited by applicant]
US 20020004580A1
· Fueyo et al.
· 2002
[cited by applicant]
US 20020025521A1
· Lu et al.
· 2002
[cited by applicant]
US 20030060436A1
· Schneider
· 2003
[cited by applicant]
US 20030171738A1
· Konieczynski et al.
· 2003
[cited by applicant]
US 20040068241A1
· Fischer
· 2004
[cited by applicant]
US 20040185042A1
· Scheiflinger et al.
· 2004
[cited by applicant]
US 20040236309A1
· Yang
· 2004
[cited by applicant]
US 20060025726A1
· Fischer et al.
· 2006
[cited by applicant]
US 20060264897A1
· Lobl et al.
· 2006
[cited by applicant]
US 20070112293A1
· Borgesen
· 2007
[cited by applicant]
US 20070173787A1
· Huang et al.
· 2007
[cited by applicant]
US 20070243179A1
· Elia
· 2007
[cited by applicant]
US 20080082036A1
· Trescony et al.
· 2008
[cited by applicant]
US 20080242590A1
· Andersson et al.
· 2008
[cited by applicant]
US 20090131857A1
· Geiger
· 2009
[cited by applicant]
US 20100030196A1
· Hildebrand et al.
· 2010
[cited by applicant]
US 20100098639A1
· Bankiewicz et al.
· 2010
[cited by applicant]
US 20100234792A1
· Dacey, Jr. et al.
· 2010
[cited by applicant]
US 20110033463A1
· Thakker et al.
· 2011
[cited by applicant]
US 20120238835A1
· Hyde et al.
· 2012
[cited by applicant]
US 20120238936A1
· Hyde et al.
· 2012
[cited by applicant]
US 20140303455A1
· Shachar et al.
· 2014
[cited by applicant]
US 20140377319A1
· Leuthardt et al.
· 2014
[cited by applicant]
US 20150201882A1
· Swoboda et al.
· 2015
[cited by applicant]
US 20160051801A1
· Vase
· 2016
[cited by applicant]
US 20160089521A1
· Dragoon et al.
· 2016
[cited by applicant]
US 20160183819A1
· Burnett et al.
· 2016
[cited by applicant]
US 20160361365A1
· Lee et al.
· 2016
[cited by applicant]
US 20170059586A1
· Petrucelli et al.
· 2017
[cited by applicant]
US 20170157038A1
· Peyman
· 2017
[cited by applicant]
US 20170313687A1
· Hendrickson et al.
· 2017
[cited by applicant]
US 20190160254A1
· Anand et al.
· 2019
[cited by applicant]
US 20200330497A1
· Marcotulli et al.
· 2020
[cited by applicant]
US 20210033620A1
· Porter et al.
· 2021
[cited by applicant]
US 20210046473A1
· Needham et al.
· 2021
[cited by applicant]
US 20210162173A1
· Singh et al.
· 2021
[cited by applicant]
US 20210379344A1
· Hakim
· 2021
[cited by applicant]
US 20220096745A1
· Riccardi et al.
· 2022
[cited by applicant]
US 20220105322A1
· Riccardi et al.
· 2022
[cited by applicant]
US 20220257854A1
· Bodner et al.
· 2022
[cited by applicant]
US 20220313890A1
· Riccardi et al.
· 2022
[cited by applicant]
US 20220355015A1
· Patel et al.
· 2022
[cited by applicant]
US 20220370716A1
· Martin et al.
· 2022
[cited by applicant]
US 20220379010A1
· Martin et al.
· 2022
[cited by applicant]
US 20220401645A1
· Morse et al.
· 2022
[cited by applicant]
US 20230056486A1
· Navia et al.
· 2023
[cited by applicant]
US 20230321412A1
· Tseng et al.
· 2023
[cited by applicant]
US 20230355118A1
· Patel et al.
· 2023
[cited by applicant]
US 20240285854A1
· Glicksman et al.
· 2024
[cited by applicant]
CN 106362226A
· 2017
[cited by applicant]
EP 1481697A1
· 2004
[cited by applicant]
EP 1731182A1
· 2006
[cited by applicant]
EP 3294398A1
· 2018
[cited by applicant]
EP 3833251A1
· 2021
[cited by applicant]
EP 4030988A1
· 2022
[cited by applicant]
JP 2002136295A
· 2002
[cited by applicant]
WO 9802441A2
· 1998
[cited by applicant]
WO 9913886A1
· 1999
[cited by applicant]
WO 9915530A1
· 1999
[cited by applicant]
WO 2000056335A1
· 2000
[cited by applicant]
WO 0114387A1
· 2001
[cited by applicant]
WO 2001039819A2
· 2001
[cited by applicant]
WO 2003015710A2
· 2003
[cited by applicant]
WO WO03015710A2
· 2003
[cited by examiner]
WO 03057218A1
· 2003
[cited by applicant]
WO 2003015710A3
· 2004
[cited by applicant]
WO 2004058337A1
· 2004
[cited by applicant]
WO 2004091444A2
· 2004
[cited by applicant]
WO 2008105959A2
· 2008
[cited by applicant]
WO 2008140546A2
· 2008
[cited by applicant]
WO 2010123558A1
· 2010
[cited by applicant]
WO 2011114260A1
· 2011
[cited by applicant]
WO 2014159247A1
· 2014
[cited by applicant]
WO 2014159757A2
· 2014
[cited by applicant]
WO 2015049588A2
· 2015
[cited by applicant]
WO 2014124365A3
· 2015
[cited by applicant]
WO 2016143227A1
· 2016
[cited by applicant]
WO 2016183123A1
· 2016
[cited by applicant]
WO 2017078695A1
· 2017
[cited by applicant]
WO 2017096228A1
· 2017
[cited by applicant]
WO 2018005621A1
· 2018
[cited by applicant]
WO 2019028006A1
· 2019
[cited by applicant]
WO 2019100074A1
· 2019
[cited by applicant]
WO 2020010074A1
· 2020
[cited by applicant]
WO 2020023417A1
· 2020
[cited by applicant]
WO 2020023418A1
· 2020
[cited by applicant]
WO 2020033773A1
· 2020
[cited by applicant]
WO 2020064875A1
· 2020
[cited by applicant]
WO 20200149993A1
· 2020
[cited by applicant]
WO 2020210634A1
· 2020
[cited by applicant]
WO 2021055100A1
· 2021
[cited by applicant]
WO 2022076598A1
· 2022
[cited by applicant]
WO 2022173620A1
· 2022
[cited by applicant]
WO 2022246042A1
· 2022
[cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2021/052735, mailed Feb. 11, 2022, 28 pages.
[cited by applicant]
Abbott, N., et al., “The role of brain barriers in fluid movement in the CNS: is there a ‘glymphatic’ system?” Acta Neuropathologica vol. 135, 2018, pp. 387-407.
[cited by applicant]
Allen, J., et al., “Abstract 3483: Modeling circulating tumor cells in the peripheral blood and CSF of breast cancer patients,” Cancer Research vol. 73, Issue 8, 2013, abstract only.
[cited by applicant]
Allen, J., et al., “Abstract 5565: Circulating tumor cells in the peripheral blood and cerebrospinal fluid of patients with central nervous system metastases,” Cancer Research vol. 72, Issue 8, 2012, abstract only.
[cited by applicant]
Andersen, P., et al., “Clinical genetics of amyotrophic lateral sclerosis: what do we really know?” Nature Reviews Neurology, vol. 7, 2011, pp. 603-615.
[cited by applicant]
Arai, T., et al., “Phosphorylated and cleaved TDP?43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP?43 proteinopathy,” Neuropathology, vol. 30, 2010, pp. 170-181.
[cited by applicant]
Arai, T., et al., “TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis,” Biochemical and Biophysical Research Communications, vol. 3…
[cited by applicant]
Arriagada, P., et al., “Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease,” Neurology 42, 1992, pp. 631-639.
[cited by applicant]
Asai, D., et al., “Chapter 3 Making Monoclonal Antibodies,” Methods in Cell Biology, vol. 37, 1993, pp. 57-74.
[cited by applicant]
Bioline “Proteinase K” accessed from bioline.com on Jun. 22, 2021 (Year: 2013).
[cited by applicant]
Brat, D., et al., “Tau?associated neuropathology in ganglion cell tumours increases with patient age but appears unrelated to ApoE genotype,” Neuropathy and Applied Neurobiology, vol. 27, Issue 3, 2001, pp. 197-205.
[cited by applicant]
Buee, L., et al., “Tau protein isoforms, phosphorylation and role in neurodegenerative disorders,” Brain Research Reviews, vol. 33, Issue 1, 2000, pp. 95-130.
[cited by applicant]
Chang, Y., et al., “The Glycine-Alanine Dipeptide Repeat from C9orf72 Hexanucleotide Expansions Forms Toxic Amyloids Possessing Cell-to-Cell Transmission Properties” Journal of Biological Chemistry, vol. 291, Issue 10, …
[cited by applicant]
Coatti, G., et al., “Pericytes Extended Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Dervised Neuronal Cells from an ALS Patient,” Stem Cell Reviews and Rep…
[cited by applicant]
De Souza, P., et al., “A biotechnology perspective of fungal proteases,” Brazilian Journal of Microbiology, vol. 46, 2, 2015, pp. 337-346.
[cited by applicant]
Dejesus-Hernandez, M., et al., “Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS,” Neuron, vol. 72, 2011, pp. 245-256.
[cited by applicant]
Diamond, S., “Methods for mapping protease specificity,” Current Opinion in Chemical Biology, vol. 11, Issue 1, 2007, pp. 46-51.
[cited by applicant]
Evidente, V., et al., “Post-encephalitic parkinsonism,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 63, Issue 1, 1998, pp. 5.
[cited by applicant]
Extended European Search Report for European Application No. 19839881.0 dated Jun. 21, 2022, 9 pages.
[cited by applicant]
Extended European Search Report for European Application No. 19840444.4 dated Jun. 28, 2022, 7 pages.
[cited by applicant]
Finsterer, J., et al., “Liquorpheresis (CSF filtration) in familial amyotrophic lateral sclerosis,” Spinal Cord, vol. 39, 1999, pp. 592-593.
[cited by applicant]
Giannakopoulos, P., et al., Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease, Neurology, vol. 60, 2003, pp. 1495-1500.
[cited by applicant]
Giordana, M., et al., “Dementia and cognitive impairment in amyotrophic lateral sclerosis: a review,” Neurological Sciences, vol. 32, 2011, pp. 9-16.
[cited by applicant]
Gomez-Isla, T., et al., Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease, Annals of Neurology, vol. 41, 1997, pp. 17-24.
[cited by applicant]
Grad, L., et al., “Prion-like activity of Cu/Zn superoxide dismutase: implications for amyotrophic lateral sclerosis,” 8:1, 2014, pp. 33-41.
[cited by applicant]
Graff-Radford, N., et al., “Frontotemporal dementia,” Seminars in Neurology vol. 27, 2007, pp. 48-57.
[cited by applicant]
Hasegawa, M., et al., “Molecular Dissection of TDP-43 Proteinopathies,” Journal of Molecular Neuroscience, vol. 45, 2011, pp. 480-485.
[cited by applicant]
Hasegawa, M., et al., “Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis,” Annals of Neurology, vol. 62, Issue 1, 2008, pp. 60-70.
[cited by applicant]
Hersh, D., et al., “MR-guided transcranial focused ultrasound safely enhances interstitial dispersion of large polymeric nanoparticles in the living brain,” PLOS One 13(2): e0192240, 2018, 19 pages.
[cited by applicant]
Indivero, V., “Technique filters cancer where chemo can't reach: A new therapy may help cancer patients with malignant ce4lls near the spinal cord and in the brain,” dated Jul. 30, 2013. Retrieved from the internet unde…
[cited by applicant]
International Preliminary Report on Patentability for International Application No. PCT/US2019/042880, mailed Jan. 12, 2021 (8 pages).
[cited by applicant]
International Preliminary Report on Patentability for International Application No. PCT/US2020/027683, mailed Oct. 21, 2021 (11 pages).
[cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2019/042879, mailed Oct. 8, 2019 (14 pages).
[cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2019/042880, mailed Oct. 16, 2019 (10 pages).
[cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2020/027683, mailed Aug. 6, 2020 (19 pages).
[cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2021/013458, mailed Jun. 9, 2021 (20 pages).
[cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2021/053829 mailed Jan. 13, 2022. 19 pages.
[cited by applicant]
International Searching Authority, International Search Report for International Application No. PCT/US2022/037609, dated Oct. 26, 2022, together with the Written Opinion of the International Searching Authority, 8 page…
[cited by applicant]
International Searching Authority, International Search Report for International Application No. PCT/US22/34706, dated Oct. 18, 2022, together with the Written Opinion of the International Searching Authority, 8 pages.
[cited by applicant]
Jessen, N., et al., “The Glymphatic System—A Beginner's Guide,” Neurochemical Research, 2015, 40(2), pp. 2583-2599.
[cited by applicant]
Kaufman, S., et al., “Prion-Like Propagatio of Protein Aggregation and Related Therapeutic Strategies,” Neurotherapeutics, 10, 2013, pp. 371-382.
[cited by applicant]
Kim Kwang Soo, et al., “Proteolytic Cleavage of Extracellular a-Synuclein by Plasmin: Implications for Parkinson Disease” Journal of Biological Chemistry, vol. 287, No. 30, Mar. 22, 2012, pp. 24862-24872.
[cited by applicant]
Kopeikina, K., et al., “Soluble forms of tau are toxic in Alzheimer's disease,” Translational Neuroscience 3(3), 2012, pp. 223-233.
[cited by applicant]
Kouzehgarani, G., et al., “Harnessing cerebrospinal fluid circulation for drug delivery to brain tissues,” Advanced Drug Delivery Reviews, 2021, vol. 173, pp. 20-59.
[cited by applicant]
Lee, V., et al., “Neurodegenerative tauopathies,” Annual Review of Neuroscience, vol. 24, 2001, pp. 1121-1159.
[cited by applicant]
Legon, W., et al., “Transcranial focused ultrasound modulates the activity of primary somatosensory cortex in humans,” Nature Neuroscience vol. 17, No. 2, 2014, pp. 322-329.
[cited by applicant]
Lei, P., et al., “Tau protein: relevance to Parkinson's disease,” The International Journal of Biochemistry & Cell Biology, vol. 42, Issue 11, 2010, pp. 1775-1778.
[cited by applicant]
Lin, Z., et al., “Facile synthesis of enzyme-inorganic hybrid nanoflowers and their application as an immobilized trypsin reactor for highly efficient protein digestion.” (Communication) RSC Adv., 2014, 4, 13888-13891.
[cited by applicant]
Lipsman, N., et al., “Blood-brain barrier opening in Alzheimer's disease using MR-guided focused ultrasound,” Nature Communications vol. 9, Article 2336, 2018, pp. 1-8.
[cited by applicant]
Lomen-Hoerth, C., et al., “The overlap of amyotrophic lateral sclerosis and frontotemporal dementia,” Neurology, vol. 59, 2002, pp. 1077-1079.
[cited by applicant]
Marx, S., et al., “Bench to Bedside: The Development of Rapamycin and Its Application to Stent Restenosis”, Journal of the American Heart Association 104, 2001, pp. 852-855.
[cited by applicant]
May, S., et al., “C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration,” Acta Neuropathologica, vol. 128, 2014, pp. 485-503.
[cited by applicant]
McKee, A., et al., “The Neuropathology of Chronic Traumatic Encephalopathy,” Brain Pathology 253), 2015, pp. 350-364.
[cited by applicant]
McRae et al., Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates. …
[cited by applicant]
Menendez-Gonzalez, M., et al., “Targeting Beta-Amyloid at the CSF: A New Therapeutic Strategy in Alzheimer's Disease,” Frontiers in Aging Neuroscience, vol. 10, 2018, pp. 1-8.
[cited by applicant]
Mori, K., et al., “The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS,” Science, vol. 339, No. 6125, Feb. 7, 2013, pp. 1335-1338.
[cited by applicant]
Narasimhan, S., et al., “Pathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain,” The Jorunal of Neuroscience, vol. 37, Issue 47, 2017, pp. 11406-11423.
[cited by applicant]
Neumann, M., et al., “Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis,” Science, vol. 314, 2006, pp. 130-133.
[cited by applicant]
Ohki, Y., et al., “Glycine-alanine dipeptide repeat protein contributes to toxicity in a zebrafish model of C9orf72 associated neurodegeneration,” Molecular Neurodegeneration (2017) 12:6, pp. 1-11.
[cited by applicant]
Ozcelik, A., et al., “Acoustic tweezers for the life sciences,” Nature Methods vol. 15, 2018, pp. 1021-1028.
[cited by applicant]
Paraskevas,G., et al., “The emerging TDP-43 proteinpathy” Neuroimmunol Neuroinflammation 5:17 (Year 2018).
[cited by applicant]
Pardridge, W., et al., “CSF, blood-brain barrier, and brain drug delivery,” Expert Opinion on Drug Delivery, vol. 13, 2016, pp. 1-13.
[cited by applicant]
Patel, A., et al., “Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patents with central nervous system metastases,” Oncotarget, vol. 2, No. 10, 2011, pp. 752-760.
[cited by applicant]
Poreba, M., et al., “Current Strategies for Probing Substrate Specificity of Proteases,” Current Medicinal Chemistry, vol. 17, Issue 33, 2010, pp. 3968-3995.
[cited by applicant]
Quinn, J., et al., “Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers,” Journal of Alzheimer's Disease, vol. 63, No. 1, 2018, pp. 13-33.
[cited by applicant]
Reinhard, M., et al., “Blood-Brain Barrier Disruption by Low-Frequency Ultrasound,” Stroke, vol. 37, 2006, pp. 1546-1548.
[cited by applicant]
Saido, T., et al., “Proteolytic Degradation of Amyloid 13-Protein” Cold Spring Harbor Perspectives in Medicine, vol. 2, No. 6, Jun. 1, 2012, pp. a006379-a006379.
[cited by applicant]
Sonabend, A., et al., “Overcoming the Blood-Brain Barrier with an Implantable Ultrasound Device,” Clinical Cancer Research, vol. 25, Issue 13, 2019, pp. 3750-3752.
[cited by applicant]
Song, J., et al., “Investigation of standing wave formation in a human skull for a clinical prototype of a large-aperture, transcranial MR-guided Focused Ultrasound (MRgFUS) phased array: An experimental and simulation …
[cited by applicant]
Spencer, B., et al., “Lentivirus Mediated Delivery of Neurosin Promotes Clearance of Wild-type a-Synuclein and Reduces the Pathology in an a-Synuclein Model of LBD”, Molecular Therapy, vol. 21, No. 1, Jan. 1, 2013, pp. …
[cited by applicant]
Steele, J., et al., “Progressive Supranuclear Palsy A Heterogeneous Degeneration Involving the Brain Stem, Basal Ganglia and Cerebellum With Vertical Gaze and Pseudobulbar Palsy, Nuchal Dystonia and Dementia,” Arch Neur…
[cited by applicant]
Takalo, M., et al., “Protein aggregation and degradation mechanisms in neurodegenerative diseases,” American Journal of Neurodegenerative Disease, 2013; 2(1), pp. 1-14.
[cited by applicant]
Tanji, K., et al., “Proteinase K-resistant a-synuclein is deposited in presynapses in human Lewy body disease and A53T a-synuclein transgenic mice,” Acta Neuropathologica, Springer, Berlin, DE, vol. 120, No. 2, Mar. 26,…
[cited by applicant]
Tarasoff-Conway, J., et al., “Clearance systems in the brain implications for Alzheimer disease,” Nature Reviews Neurology 11(8), 2015, pp. 457-470.
[cited by applicant]
Tyler, W., et al., “Remote Excitation of Neuronal Circuits Using Low-Intensity, Low-Frequency, Ultrasound,” PLOS One vol. 3, Issue 10, 2008, e3511, 11 pages.
[cited by applicant]
Westergard, T., et al., “Cell-to-Cell Transmission of Dipeptide Repeat Proteins Linked to C9orf72-ALS/FTD,” Cell Reports, vol. 17, Issue 3, 2016, pp. 645-652.
[cited by applicant]
Wray, S., et al., “Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N?terminally cleaved tau containing four microtubule?binding repeats,” Journal of Neurochemistry, vol…
[cited by applicant]
Written Opinion of the International Preliminary Examining Authority for International Application No. PCT/US2019/042879, mailed Feb. 25, 2021 (6 pages).
[cited by applicant]
Written Opinion of the International Preliminary Examining Authority for International Application No. PCT/US2019/042880, mailed Sep. 11, 2020 (8 pages).
[cited by applicant]
Wszolek, Z., et al., “Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)” Orphanet Journal of Rare Diseases, 2006, 1:30, pp. 1-9.
[cited by applicant]
Xie, L., et al., “Sleep Drives Metabolite Clearance from the Adult Brain,” Science vol. 342, Issue 6156, 2013, pp. 373-377.
[cited by applicant]
Zhang, Y., et al., “Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress,” Acta Neuropathologica, vol. 128, 2014, pp. 504-524.
[cited by applicant]
Extended European Search Report for application No. PCT/US021052735 dated Oct. 8, 2024 (18 pages).
[cited by applicant]
Chinese Office Action for Chinese Application No. 202080041867.5, dated Jul. 12, 2023 (12 pages).
[cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US23/17893, mailed Jun. 29, 2023 (13 pages).
[cited by applicant]
International Searching Authority, International Search Report for International Application No. PCT/US2024/017736, dated Aug. 19, 2024, together with the Written Opinion of the International Searching Authority, 15 pag…
[cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2023/015972, mailed Jul. 27, 2023, 12 pages.
[cited by applicant]
International Preliminary Report on Patentability for International Application No. PCT/US2022/034706 mailed Jan. 4, 2024 (7 pages).
[cited by applicant]
First Chinese Office Action for Chinese Patent Application No. 202080041867.5, with English translation, dated Jul. 12, 2023 (24 pages).
[cited by applicant]
Notice of Reasons for Refusal for Japanese Patent Application No. 2021-560113, with English translation, dated Jan. 4, 2024 (12 pages).
[cited by applicant]
Second Chinese Office Action for Chinese Patent Application No. 202080041867.5, with English translation, dated Apr. 30, 2024 (26 pages).
[cited by applicant]
Extended European Search Report for European Patent Application No. 20788080.8, dated Jun. 4, 2024 (12 pages).
[cited by applicant]
Non-Final Office Action for U.S. Appl. No. 17/489,633 dated May 29, 2024 (8 pages).
[cited by applicant]
Office Action Decision of Refusal from Japanese Patent Office for application No. 2021-560113 dated Jun. 25, 2024, 5 pages.
[cited by applicant]
International Search Report and Written Opinion for PCT/2024/017736 dated Aug. 19, 2024, 15 pages.
[cited by applicant]